Novitium Pharma LLC recalls Digoxin Tablets
FDA Class III
FDA classified this recall as Class III: the product is unlikely to cause health problems but breaks the agency's rules (a labeling mistake, for example).
- Hazard
- Cross Contamination with Other Products:(mycophenolate mofetil).
- Products
-
- Digoxin Tablets
- Company
- Novitium Pharma LLC
- Where it was sold
-
Nationwide in the USA
Nationwide
- Units affected
- 3,940 1000-count bottles
- About this recall
- Digoxin Tablets, USP 125mcg, (0.125 mg), 1000-count bottle, Rx Only, Manufactured by: Novitium Pharma LLC., 70 Lake Drive, East Windsor, New Jersey 08520, NDC 70954-201-20